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ABSTRACT Although a glutamate-gated chloride con-
ductance with the properties of a sodium-dependent gluta-
mate transporter has been described in vertebrate retinal
photoreceptors and bipolar cells, the molecular species un-
derlying this conductance has not yet been identified. We now
report the cloning and functional characterization of a human
excitatory amino acid transporter, EAAT5, expressed primar-
ily in retina. Although EAAT5 shares the structural homolo-
gies of the EAAT gene family, one novel feature of the EAAT5
sequence is a carboxy-terminal motif identified previously in
N-methyl-D-aspartate receptors and potassium channels and
shown to confer interactions with a family of synaptic proteins
that promote ion channel clustering. Functional properties of
EAAT5 were examined in the Xenopus oocyte expression
system by measuring radiolabeled glutamate f lux and two-
electrode voltage clamp recording. EAAT5-mediated L-
glutamate uptake is sodium- and voltage-dependent and chlo-
ride-independent. Transporter currents elicited by glutamate
are also sodium- and voltage-dependent, but ion substitution
experiments suggest that this current is largely carried by
chloride ions. These properties of EAAT5 are similar to the
glutamate-elicited chloride conductances previously de-
scribed in retinal neurons, suggesting that the EAAT5-
associated chloride conductance may participate in visual
processing.
The uptake of glutamate and other excitatory amino acids is
mediated by a gene family of high affinity sodium-dependent
transporters that includes four known mammalian subtypes; in
humans, we have termed these glutamate transporters excita-
tory amino acid transporter (EAAT) 1 through 4 (1, 2). The
transport of glutamate is driven by the cotransport of sodium
ions and the countertransport of potassium ions down their
electrochemical gradients, and recent studies suggest that this
complex process involves the cotransport of protons as well
(3–6). Because there is net inward movement of positive
charge with the transport of each molecule of glutamate, the
transport process is readily studied in the Xenopus oocyte
expression system by observing the associated current. In
addition to these transport currents, however, we have found
that application of substrate to the transporter also gates an
uncoupled, passive flux of chloride ions (2, 7). The relative
magnitude of this associated chloride conductance varies with
each cloned EAAT subtype; for EAAT1–EAAT3, the mag-
nitude of the chloride current at physiological membrane
potentials is similar to that of the electrogenic cotransport
current, but the currents generated by EAAT4 are almost
entirely due to the flux of chloride ions. In vivo, a glutamate-
dependent current that has a transporter-like pharmacology is
carried largely by chloride ions in retinal cone (8) and rod (9)
photoreceptors and bipolar cells (10). In bipolar cells, this
chloride current has been proposed to mediate the cone
component of the ON bipolar cell light response (10). Al-
though the properties of EAAT4 are similar to the glutamate-
elicited current in the retinal neurons, EAAT4 is almost
exclusively expressed in cerebellum (2) and therefore was
unlikely to account for the retinal activity.
To gain insight into the molecular basis of glutamate trans-
porter physiology in the retina, we are currently characterizing
EAAT subtypes expressed in a well described model system,
the salamander retina. One of the glutamate transporters
isolated from this tissue is associated with a large chloride
conductance when expressed in Xenopus oocytes and exhibits
a pharmacology similar to that previously reported in the
retinal cells (unpublished work). We have isolated the human
homolog of this gene by screening a human retinal cDNA
library with the salamander cDNA. Here, we report the
cloning and characterization of a human retinal glutamate
transporter subtype, EAAT5.
EXPERIMENTAL PROCEDURES
Molecular Cloning and Sequencing. A glutamate trans-
porter cDNA isolated from salamander retina (unpublished
work) was used to screen a human retinal lgt10 cDNA library
[provided by J. Nathans (11)] under conditions of reduced
stringency. Plaque filter lifts prepared as per the manufactur-
er’s instructions (GeneScreen; New England Nuclear) were
hybridized overnight at 558C in 0.5 M Na2HPO4, pH 7.15/7%
SDS/1 mM EDTA with the salamander cDNA probe coding
sequence 32P-radiolabeled by random priming at 1 3 106
cpm/ml (Boehringer Mannheim). Filters were washed at 558C
in 23 standard saline phosphate/EDTA (SSPE) (203 SSPE5
3 M NaCl/0.2 M NaH2PO4/0.02M Na2 EDTA, pH 7.4) and 1%
SDS. The EcoRI inserts from purified phage clones were
subcloned into pBluescript II SK (Stratagene) and character-
ized. The complete coding sequences of two clones were
subsequently sequenced on both strands using double-
stranded template, synthetic oligonucleotide primers, PRISM
PCR-based sequencing reactions (Applied Biosystems), and
an Applied Biosystems 373 Stretch DNA Sequencer. Sequence
data analyses and comparisons were performed using
MacVector (Kodak). The 2.9-kbp insert of one clone, termed
‘‘pEAAT5,’’ has '180 bp of 59 untranslated region containing
two in-frame stop codons upstream of the Kozak consensus
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(ACCATGG) initiator methionine, 1683 bp of coding se-
quence, and '1.1 kbp of 39 untranslated region. Polyadenyl-
ylation in the other EAAT5 isolate suggested a total message
size of '3.1 kb, consistent with retinal Northern blot analyses.
Northern Blot Analyses. Human retinal poly(A)1 RNA (2
mg) was size-fractionated on a denaturing formaldehyde gel
and transferred to nylon membrane. The human retina RNA
and Multiple Tissue Northern blot (model 7760–1) were
obtained from CLONTECH. The coding sequence of EAAT5
was excised and radiolabeled with a[32P]dCTP (New England
Nuclear) by the random priming method (Boehringer Mann-
heim). Filters were hybridized overnight at 428C with cDNA
probe (106 cpm/ml) in 5X SSPE, 50% formamide, 7.5X
Denhardt’s solution, 2% SDS, and 100 mg/ml of denatured
salmon sperm DNA. Autoradiography was performed after
two 30-min room temperature washes in 2X SSPE/0.1% SDS
and two 20-min washes at 508C in 0.1X SSPE/0.1% SDS.
Membranes were subsequently stripped and rehybridized with
a b-actin probe according to the manufacturer’s protocol.
Expression and Electrophysiology. The coding sequence of
EAAT5 was isolated by PCR for subcloning. Unique flanking
restriction sites (Asp718 and XbaI) were incorporated via the
oligonucleotide primers 59-CGCG GGTAC CTC ACC ATG
GTG CCG CAT-39 and 59-CGCG TCTAGA GGC TCAGAC
ATT GGT CTC-39. Twenty five cycles of denaturation (30 s,
948C), annealing (30 s, 558C), and extension (2 min, 728C) were
performed in 100-ml reactions that contained oligonucleotide
primers at 1 mM each, 10 ng of plasmid cDNA template, and
300 mM each of deoxynucleotide, Vent polymerase, and
reaction buffer (New England Biolabs). Digestion of the
reaction products with Asp718 and XbaI allowed each coding
sequence to be subcloned into plasmid pOTV for expression in
Xenopus laevis oocytes as described (1). The resulting plasmid,
termed ‘‘pOTV-EAAT5,’’ was linearized with SpeI and syn-
thetic RNA transcribed using T7 RNA polymerase and an
mMessagemMachine RNA capping kit (Ambion, Austin, TX).
EAAT5 RNA was microinjected into defolliculated stage
V-VIXenopus oocytes and used for experiments 2–5 days later.
For uptake and electrophysiological experiments, the extra-
cellular Ringer’s solution consisted of (in millimolars): 96
NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, and 5 Hepes. The pH,
adjusted with NaOH, was 7.5. For sodium-free solutions, 96
mM NaCl was replaced with 96 mM N-methyl D-glucamine
(NMDG)-chloride, and the pH was adjusted with NMDG. For
chloride-free solutions, all chloride salts were replaced with
gluconate salts. Nitrate extracellular solution contained 96
mM NaNO3 instead of NaCl.
Radiolabeled glutamate uptake was performed under volt-
age clamp at 260 mV (except, as noted, 110 mV). Currents
were recorded during bath application of 100 mM [3H]-L-
FIG. 1. EAAT5 is a member of the human glutamate transporter gene family. (A) The predicted amino acid sequences of human EAAT5 is
shown in alignment with the other known human EAAT subtypes (1, 2). In this alignment, amino acid residues identical in four of the five sequences
are shown in white on black lettering to illustrate the extensive amino acid sequence conservation in this gene family. Although the transmembrane
topology of these transporters is not well defined, one possible model is indicated here. The poorly conserved amino- and carboxy-terminal
sequences are likely to be intracellular, and eight regions with strong transmembrane (TM) scores are indicated by bars and suggested orientation
(i, inside; o, outside). The large conserved hydrophobic sequence (LCHS) indicated between TMs VII and VIII may be membrane-associated.
Possible N-linked glycosylation sites (N-X-S or T) in a large extracellular loop are boxed. (B) The carboxyl terminus of EAAT5 conforms to a
sequence motif (E-S or T-X-V) involved in subcellular targeting. NMDA receptor subunits NR2A and NR2B (12) and potassium channel Kv1.4
(13) interact with PSD-95 via their C termini.
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glutamate for 100 s. The specific activity of the [3H]-L-
glutamate (Amersham) in this solution was 20 Ci/mol (1 Ci 5
37 GBq). Oocytes were washed in the bath for 3 min to
minimize background radioactivity and then individually lysed
in a scintillation vial containing 1% SDS for .15 minutes
before adding scintillation fluid and counting.
Two microelectrode voltage-clamp recordings were per-
formed using a GeneClamp 500 amplifier interfaced to a
Digidata 1200 A/D and controlled using pClamp6 (Axon
Instruments, Foster City, CA). Recording electrodes con-
tained 3 M KCl with resistances ,1 MOhm. Currents were
filtered at 2 kHz and digitized at 5 kHz. For current–voltage
curves, the oocyte membrane potential was held to 230 mV
and stepped through a range of potentials from 150 to 2100
in 100-ms steps. Steady state currents were measured during
the final 20 ms of the command step.
RESULTS
Cloning of EAAT5. The isolation of an EAAT subtype from
salamander retina whose sequence differed substantially from
previously reported mammalian sequences lead us to isolate
the human homolog EAAT5. The predicted human EAAT5
gene product is 560-amino acid residues in length, as depicted
in the sequence comparison with other EAAT subtypes in Fig.
1A, and has a theoretical molecular mass of 61 kDa. Like other
members of this gene family, EAAT5 is likely to be a glyco-
protein, but EAAT5 differs in that there is only a single
N-linked glycosylation site (N-X-S or T) in the putative large
extracellular loop. With an optimal sequence alignment,
EAAT5 has 46% identity with EAAT1, 43% identity with
EAAT4, 37% with EAAT3, and 36% identity with EAAT2.
For comparison, EAAT1 has 52% identity with EAAT4 and
49% with EAAT3. The most striking sequence conservation is
found in a large conserved hydrophobic sequence that includes
the sequence AAIFIAQ (residues 388–394 in EAAT5; Fig.
1A). However, the amino- and carboxy-terminal sequences of
this gene family, thought to be intracellular, are poorly con-
served. Of interest, the amino acid residues at the EAAT5 C
terminus conform to a sequence motif found in synaptic
membrane proteins: E-S or T-X-V-COOH [see review by
Sheng (14)]. A comparison of the EAAT5 C-terminal se-
quence with those of the NMDA receptor subunits NR2A and
NR2B and the Shaker-type potassium channel Kv1.4 ion
channels, whose interactions with postsynaptic density-95 pro-
tein (PSD-95) have been studied extensively, is shown in Fig.
1B. The C termini interact with several PDZ (a modular
protein-binding motif) domains in PSD-95 (14), and prelimi-
nary results using the yeast two hybrid assay for protein–
protein interactions indicate an ability of EAAT5 to interact
with these PDZ domains (J.A., unpublished observations).
Distribution by Northern Blotting. Northern Blot analyses
indicate that a 3.1-kb EAAT5 RNA species is abundantly
expressed in human retina (Fig. 2). A band of approximately
the same size also was detectable in liver, but at a level at least
20-fold lower. Weak, '2.0-kb bands also were seen in heart
and muscle, and a very light band at '4.5 kb was found in
brain. It is not known if these differently sized bands reflect
differential processing of the same gene or if there is cross-
hybridization with a very closely related gene, but the sizes do
not correspond to those reported for other human EAATs (1,
2). The weak hybridization with total brain RNA might reflect
a restricted brain distribution; to address this issue, 20 mg of
total RNA isolated from six human brain regions was analyzed
by Northern blotting (frontal and motor cortex, hippocampus,
thalamus, basal ganglia, and cerebellum), and no signal was
detected (data not shown). Although these distribution studies
were not exhaustive, the data suggest that expression of
EAAT5 is relatively retina-specific.
Functional Properties. Xenopus oocytes injected with RNA
transcribed from the EAAT5 cDNA were tested for their
ability to take up exogenously applied glutamate. Uptake of
radiolabeled glutamate was significantly increased over unin-
jected control oocytes (typically 2- to 10-fold) but was less than
observed for EAAT1-, EAAT2-, or EAAT3-expressing oo-
cytes (typically .50-fold). It is not clear whether this differ-
ence reflects a lower turnover rate for EAAT5 or reduced
expression, but this is a characteristic shared with EAAT4.
Radiolabeled L-glutamate (100 mM) was applied for 100 s
while the oocyte membrane potential was held at 260 mV
using a two-electrode voltage clamp (Fig. 3A). The [3H]-L-
glutamate content of EAAT5 oocytes was 2.3-fold greater than
in uninjected oocytes not expressing EAAT5 (P 5 0.013,
unpaired two-tailed t test). EAAT5 uptake was sodium-
dependent and voltage-dependent, with no significant differ-
ence from controls observed when external sodium was re-
placed by NMDG or when the membrane potential was
clamped at 110 mV (P . 0.29). Similar to EAAT1–4 (2, 7),
uptake was not significantly affected by replacing external
chloride with the larger anion gluconate (P 5 0.55).
Application of glutamate to oocytes expressing EAAT5
generated a current that was both voltage- and concentration-
dependent (Fig. 3B). The current reverses at2206 1 mV, and
this reversal potential was not affected by the glutamate
concentration. An outward current is not predicted for an
electrogenic transporter mediating coupled flux but is similar
to the currents present in other glutamate transporters, par-
ticularly the EAAT4 subtype (2). The ionic basis for this
outward current is explored below. Currents also were elicited
by both L- and D-aspartate and, much less potently, by D-
glutamate. The apparent affinity (EC50) and relative maximal
current (Imax) for these compounds with the membrane po-
tential held at 260 mV are shown in Table 1. EAAT5 exhibits
considerable stereospecificity for L-glutamate vs. D-glutamate
and a slight preference for L-aspartate over D-aspartate. The
affinity for L-glutamate is modestly voltage-dependent; the
EC50 increases e-fold per 86 mV.
L-trans-pyrollidine-2,4- dicarboxylic acid (tPDC) and threo
b-hydroxyaspartate (THA) are potent blockers of both glu-
FIG. 2. EAAT5 mRNA is most abundantly expressed in the retina.
The EAAT5 cDNA was used for hybridization of Northern-blotted
poly(A)1 RNAs (2 mg) from retina and other human tissues. The
retinal signal, a single 3.1-kb band, was overexposed here so that
additional EAAT5-hybridizing bands in other tissue RNAs could be
seen. Lower, the same blots were hybridized with a b-actin probe to
control for RNA loading in each lane.
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tamate uptake (Fig. 3A) and the glutamate-elicited current in
EAAT5-expressing oocytes (Fig. 3,C andD). Currents elicited
by 100 mM glutamate were almost entirely blocked by coap-
plication of 100 mM tPDC or 100 mM THA. From Schild
analysis, EAAT5 has an apparent affinity (Ki) for tPDC and
THA of 6.2 6 1.7 mM and 1.0 6 0.1 mM, respectively.
Although both compounds are competitive substrates of other
EAAT subtypes (1), neither blocker generated a current with
a voltage dependence similar to that of glutamate. On the
contrary, either tPDC or THA alone elicited currents that
were outward at negative potentials and became small and
inward at positive potentials (Fig. 3, C and D); this current,
which is not seen in uninjected controls, may reflect the block
of an EAAT5-mediated current that is independent of external
amino acid. In contrast to the effects of tPDC and THA, the
high affinity EAAT2 subtype blocker kainate had minimal
effects on EAAT5 function. In five cells, 1 mM kainate
reduced the response to 100 mM glutamate to 84 6 11% of
control over the range of 2100 to 240 mV (data not shown).
The dependence of EAAT5 glutamate-elicited currents on
sodium and chloride ions was examined. As with uptake,
glutamate-elicited currents in EAAT5 expressing oocytes re-
quire extracellular sodium; no currents were observed when
sodium was replaced with NMDG (Fig. 4A). Replacing extra-
cellular chloride with the larger anion gluconate eliminated
the outward current elicited by 100 mMglutamate but had only
a negligible effect on the inward current (Fig. 4B). This
suggests that at least a portion of the glutamate-elicited
outward current is due to the passive flux of chloride ions, as
has been reported for the other human glutamate transporters
(2, 7). To determine the relative contribution of chloride flux
FIG. 3. Pharmacology of EAAT5-mediated uptake and currents. (A) Uptake of [3H]-L-glutamate (100 mM) in oocytes voltage-clamped at 260
mV in normal Ringers solution (96 mM NaCl) (normal) or sodium-free (0 Na1) or chloride-free Ringers (0 Cl2) or voltage-clamped at 110 mV
in normal Ringers. Uptake was sodium- and voltage-dependent. Additionally, uptake (260 mV, normal Ringers) was blocked by coapplication of
100 mM THA or tPDC. p, Differs significantly from uptake measured in control uninjected oocytes. Data are the average of five cells each. (B)
Dose- and voltage-dependent steady-state currents due to the application of L-glutamate to EAAT5-expressing oocytes. Concentration of
L-glutamate indicated in the legend. Data are the average of seven cells. (C) Steady-state current elicited by 100mML-glutamate (squares) is blocked
by coapplication of 100 mM tPDC (triangles); 100 mM tPDC alone (circles) elicits a small outward current at hyperpolarized potentials. Data are
the average of four cells. (D) Steady-state current elicited by 100 mM L-glutamate (squares) is blocked by coapplication of 100 mMTHA (triangles);
100 mM THA alone (circles) elicits a small outward current at hyperpolarized potentials. Data are the average of six cells. All error bars represent
SEM. Error bars smaller than the symbols are not shown.
Table 1. EAAT5 pharmacology
Compound n EC50, mM Imax
L-glutamate 5 64 6 6 (1)
D-glutamate 4 .10,000 (0.21 6 0.06)*
L-aspartate 5 13 6 5 0.67 6 0.20
D-aspartate 4 64 6 10 0.72 6 0.03
THA 6 1.0 6 0.1 (0)†
tPDC 4 6.2 6 1.7 (0)†
Imax is normalized to L-glutamate Imax in the same oocyte.
*Relative current elicited by 10 mM D-glutamate.
†Determined by Schild analysis; THA and PDC did not induce
currents.
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to the inward current, internal chloride was reduced by dia-
lyzing the oocytes in a chloride-free medium for at least 48 h.
Under these conditions, application of 100 mM glutamate in
the absence of external chloride produced no measurable
current in 10 cells (Fig. 4C; dialyzed). In contrast, 10 cells from
the same batch of oocytes were kept in a normal chloride
medium and exhibited normal glutamate-elicited currents
(Fig. 4C; control). Thus, it appears that both the inward and
outward currents elicited by glutamate in EAAT5 are due
primarily to the passive flux of chloride ions, similar to what
has been reported for EAAT4. Finally, we investigated the
effect of replacing extracellular chloride with the anion nitrate
(Fig. 4D). As with other glutamate transporters (7, 15), nitrate
substantially increased the glutamate-elicited outward current
due to the influx of a more permeant external anion.
DISCUSSION
We have identified a novel mammalian glutamate transporter,
EAAT5, whose mRNA is abundantly expressed in the retina
and whose properties are consistent with a glutamate-gated
chloride conductance associated with both presynaptic (16)
and postsynaptic (10) aspects of the retinal light response.
Electrophysiological studies in retinal photoreceptors (9, 17)
and bipolar cells (10) have reported glutamate-gated currents
that reverse at potentials close to the equilibrium potential for
chloride and are diminished by removal of extracellular or
intracellular chloride, suggesting that the currents are carried
largely by chloride ions. These currents are not associated with
known types of glutamate receptors because they are neither
activated by receptor agonists nor inhibited by receptor block-
ers (8–10). However, the currents share several properties with
glutamate transporters: They are sodium-dependent, activated
by L-glutamate and L- and D-aspartate but not D-glutamate,
and reduced by the coapplication of transport inhibitors such
as THA and tPDC.
We find that human EAAT5 exhibits the ion-dependence
and most of the pharmacological properties of the retinal
activities described previously, yet there are a few differences.
Unlike salamander rods (9) or fish bipolar cells (10), in which
THA and tPDC alone produce small but measurable inward
currents, these compounds do not induce EAAT5-mediated
inward currents. Rather, the application of these compounds
alone appears to reduce an EAAT5 leak current. This differ-
ence may be the result of differences between the human and
lower vertebrate homologs of EAAT5 because THA and
tPDC produce inward currents in the salamander homolog of
EAAT5 (unpublished work). Another pharmacological differ-
FIG. 4. Ionic dependence of EAAT5-mediated currents. (A) Steady-state current elicited by 100 mM L-glutamate (circles) is abolished when
external sodium is replaced with NMDG (squares). Data are the average of five cells. (B) Steady-state current elicited by 100 mM L-glutamate in
normal chloride (circles) or when external chloride was replaced with gluconate (squares). Removal of external chloride ions blocks outward current
at positive potentials and has no effect at negative potentials. Data are the average of five cells. (C) Steady-state current elicited by 100 mM
L-glutamate in normal oocytes (circles) or in oocytes dialyzed in chloride-free solution for.48 h (squares). No currents are seen in oocytes dialyzed
to remove chloride ions. Data are the average of 10 cells for each condition. (D) Steady-state current elicited by 100 mM L-glutamate in normal
chloride (circles) or whenmost external chloride was replaced with nitrate (squares). L-glutamate elicited current in nitrate produces a large outward
current. Data are the average of six cells. All error bars represent SEM. Error bars smaller than the symbols are not shown.
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ence between EAAT5 and the photoreceptor currents is that
the currents in both rods (9) and cones (8) are somewhat
sensitive to dihydrokainate, a transporter blocker similar to
kainate. This may be caused by expression of multiple subtypes
of glutamate transporters in a single cell. Such colocalization
of glutamate transporter subtypes has been observed in the
brain (18–20), and we have immunocytochemical evidence to
suggest that this occurs extensively in the salamander retina as
well (unpublished work).
There is accumulating evidence that the functional activities
of glutamate transporters may extend beyond a conventional
role in neurotransmitter clearance. Recent antisense knockout
experiments suggest that the rat homologs of EAAT1,
EAAT2, and EAAT3 [GLAST (21), GLT1 (22), and EAAC1
(23)] mediate the bulk of glutamate and aspartate uptake in
the brain (24). This activity is essential in the nervous system,
where glutamate serves as the major excitatory neurotrans-
mitter yet is also a potent excitotoxin. Electrophysiological
studies of EAAT4, and now EAAT5, demonstrate a relatively
large chloride conductance associated with transport activity.
The chloride conductances of EAAT4 and EAAT5 are of
great interest because they suggest a function more akin to
ligand-gated chloride channels than classic transporters. Both
pre- and postsynaptic glutamate-gated chloride conductances
have been examined in the vertebrate retina. In perch retina,
the cone-mediated light response in depolarizing bipolar cells
is due to the closing of a postsynaptic chloride conductance
that has the pharmacology and ionic dependence of a gluta-
mate transporter (10). Presynaptically, a glutamate-elicited
chloride conductance with transporter-like properties in
salamander cone photoreceptors recently has been demon-
strated to respond to the release of glutamate from the same
cell (16). The chloride equilibrium potential is more negative
than the voltage-operating range of cones, so this EAAT5-like
molecule may act as an inhibitory autoreceptor.
The protein-binding structure at the C terminus of EAAT5
has intriguing functional implications. We have found that the
EAAT5 coding sequence contains a protein-binding motif
recently identified as a mechanism for receptor and ion
channel clustering at the synapse (14). It has been demon-
strated that the cytoplasmic C terminus of NMDA receptor
subunits (12, 25) and of Shaker-type potassium channels (13)
physically bind PSD-95, an abundant synaptic protein associ-
ated with the membrane cytoskeleton (26). These C termini
bind to multiple PDZ domains present in PSD-95, and the
crystal structure of PDZ domains recently was examined to
determine how a relatively short C-terminal peptide sequence
is specifically bound (27, 28). The critical C-terminal deter-
minants for binding to PDZ domains are present in the
EAAT5 C terminus (Fig. 1B), and we have preliminary data
from the yeast two-hybrid system that support a EAAT5–PDZ
domain interaction (J.A., unpublished observations). PSD-95
is itself a member of a family of synaptic proteins containing
PDZ domains (14, 25, 29–31), so it is not readily apparent
which protein or proteins might serve as functional partners of
EAAT5 in vivo. The discovery of this binding motif in EAAT5
suggests that EAAT5 resides in the vicinity of components of
the signal transduction pathway where its channel-like prop-
erties may indicate a role in retinal physiology distinct from
neurotransmitter clearance.
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